Siemens Healthineers AG became the latest company to sign a licensing agreement with Alzpath Inc. to use its pTau217 antibody ...

Paul Boehm, who had co-chaired the firm's FDA practice group at W&C, has joined Sidley Austin in Washington, D.C.

Global Hematology Market OverviewThe global hematology market is projected to grow at a CAGR of approximately 3–5% through ...

The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...

Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to ...

ALZpath, Inc. , a leading developer of innovative diagnostic tools for Alzheimer's and related diseases, today announced that the Simoa® ALZpath pTau217 Assay was used in a landmark ...

Siemens Healthineers will utilize ALZpath's high-performing, proprietary pTau217 antibody in its growing test menu for its Atellica analyzers to enable IVD testing for Alzheimer's disease CARLSBAD, ...

According to Mordor Intelligence, the global exosomes market is valued at USD 0.71 billion in 2025 and is projected to surpass USD 2.21 ...

After a period of underwhelming performance this year, positive developments are emerging for the life sciences conglomerate Danaher. A key product introduction and encouraging analyst commentary are ...

The main market opportunities lie in expanding Whole Genome Sequencing at birth, rapid growth in Direct to Consumer Testing, advancing sequencing technologies, and overcoming industry barriers.

Companion Diagnostics are revolutionizing the diagnostics industry, creating dynamic opportunities in diagnostic and therapeutic partnerships. Companies are strategically aligning with pharmaceutical ...